BioNTech Gets $445 Million in German Funding for Vaccine

Bookmark
(Bloomberg) -- BioNTech SE will get as much as 375 million euros ($445 million) from Germany to back its Covid-19 vaccine program, about half of the money the government set aside to accelerate dev...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.